3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial.

Autor: Ot'alora G M; 1 Aguazul-Bluewater, Inc., Boulder, CO, USA., Grigsby J; 2 Department of Psychology, University of Colorado, Denver, CO, USA., Poulter B; 1 Aguazul-Bluewater, Inc., Boulder, CO, USA., Van Derveer JW 3rd; 3 Integrative Psychiatric Healing Center, Boulder, CO, USA., Giron SG; 4 Multidisciplinary Association for Psychedelic Studies (MAPS), Boulder, USA., Jerome L; 5 MAPS Public Benefit Corporation, Boulder, CO, USA., Feduccia AA; 5 MAPS Public Benefit Corporation, Boulder, CO, USA., Hamilton S; 6 Stanford School of Medicine, Stanford, CA, USA., Yazar-Klosinski B; 4 Multidisciplinary Association for Psychedelic Studies (MAPS), Boulder, USA., Emerson A; 5 MAPS Public Benefit Corporation, Boulder, CO, USA., Mithoefer MC; 7 Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA., Doblin R; 4 Multidisciplinary Association for Psychedelic Studies (MAPS), Boulder, USA.

Publikováno v: Journal of psychopharmacology (Oxford, England) [J Psychopharmacol] 2018 Dec; Vol. 32 (12), pp. 1295-1307. Date of Electronic Publication: 2018 Oct 29.